Several factors were reported to be associated with pathological underestimation in previous studies, including palpability, high nuclear grade, BI-RADS category 5, HER2 positivity, Ki-67 overexpression, suspicious invasion, mammographic mass finding, and radiological tumor size ≥ 2.0 cm5,7–12. The gene discussed is ERBB2; the disease is neoplasm.